ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,586Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 434

$431K Total Retail Price of All Prescriptions

Rank: 60 out of 434

311 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 311 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 311 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 6,025 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
SIMVASTATIN 519 389 1 2
OMEPRAZOLE 382 305 2 5
LISINOPRIL 329 232 3 1
METFORMIN HCL 265 190 4 7
AMLODIPINE BESYLATE 232 206 5 6
LEVOTHYROXINE SODIUM 214 182 6 3
ZOLPIDEM TARTRATE 178 166 7 11
FLUOXETINE HCL 156 149 8 32
HYDROCHLOROTHIAZIDE 132 108 9 8
GABAPENTIN 129 103 10 14
NAPROXEN 122 106 11 75
METOPROLOL TARTRATE 122 94 11 12
ALENDRONATE SODIUM 115 113 13 15
GLIMEPIRIDE 110 88 14 58
TAMSULOSIN HCL 105 90 15 29
CITALOPRAM HBR 92 55 16 23
ACTOS 92 84 16 85
FUROSEMIDE 92 69 16 9
DONEPEZIL HCL 91 91 19 35
IBUPROFEN 91 48 19 56
ATORVASTATIN CALCIUM 83 76 21 19
AZITHROMYCIN 81 61 22 38
TRAMADOL HCL 80 77 23 28
GLYBURIDE-METFORMIN HCL 79 79 R 24 118
CLOTRIMAZOLE-BETAMETHASONE 77 72 25 124
DIOVAN 74 72 26 105
CLOPIDOGREL 70 66 27 41
CARVEDILOL 66 44 28 24
CELEBREX 62 48 29 144
LANTUS SOLOSTAR 60 35 30 71
PROAIR HFA 60 38 30 60
DICLOFENAC SODIUM 60 50 30 92
GEMFIBROZIL 59 37 33 62
CRESTOR 59 59 33 84
DIOVAN HCT 56 56 35 151
PLAVIX 55 52 36 64
HYDROCODONE-ACETAMINOPHEN 53 46 S3 37 4
RANITIDINE HCL 52 46 38 31
LOSARTAN POTASSIUM 52 48 38 13
VENTOLIN HFA 50 42 40 30
POTASSIUM CHLORIDE 50 34 40 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 17, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.